Study of people diagnosed with fatty liver from not-too-much alcohol
Part of Digestive system clinical trials.
This is an observational study for people diagnosed with nonalcoholic fatty liver disease (fatty buildup in the liver not mainly caused by heavy drinking). It may help researchers better understand this condition, especially how it shows up on tests and how people report relevant health information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with nonalcoholic fatty liver disease (fatty liver not mainly from heavy alcohol use).
- You do not have signs that alcohol use is excessive.
- You are able to participate and cooperate with study activities (for example, no severe memory problems or serious uncontrolled illnesses that prevent participation).
- You can provide complete required health test results, including hepatitis B blood test results and an abdominal ultrasound report.
- You agree to sign the informed consent form (your participation is voluntary).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with nonalcoholic fatty liver disease to better understand the condition. It uses an MRI scan and collects body samples to help researchers study changes over time.
This study measures different fats and proteins in the liver of people with fatty liver disease (often called NAFLD) who are having planned abdominal or weight-loss surgery. It may help doctors better understand what’s happening in the liver and improve future care.
This study looks at people with type 2 diabetes who also have fatty liver. The goal is to learn more about this condition in a Saudi group and test approaches that could improve care.
This study follows people who have been confirmed to have fatty liver disease seen on a liver sample. It aims to understand the condition over time and how different causes and health factors may affect it.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
Hear when a new Non-Alcoholic Fatty Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.